REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/02/2026
Back to search
Official data from USPTO
PATIENT IN THE LAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PATIENT IN THE LAB
ST13
US500000079295548Class
1, 5, 42, 44
Filing
79295548
Registration
6279684
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/03/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
05/22/2020
Registration date
03/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
78
Owner location
NL
Examiner
MCNAMARA, JAMES
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HUB Organoids IP B.V.
HUB Organoids B.V. IP
S. T. (pessoa física)
Representatives
William C. Wright Epstein Drangel LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cellsstem cellsepithelial cellsall for scientific research purposes; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell culturesfor scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes
Class 5
Cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; stem cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; stem cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; epithelial cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; epithelial cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cell cultures for medical and veterinarydiagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cell cultures for medical and veterinarydiagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cellscultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx
Class 42
Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compounddrug and vaccine discoverydevelopment servicescharacterization and validation services in the nature of product quality and efficacy testing for medical compoundsdrugs and vaccines; candidate drug and vaccinedrug and vaccine testing servicestesting of pharmaceuticals; companion diagnosticsthe scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine
Class 44
Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
Publications
History of USPTO decisions and trademark events.
23 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/28/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/28/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/28/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/07/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2021
FIMP
FINAL DISPOSITION PROCESSED
04/02/2021
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2021
PUBO
PUBLISHED FOR OPPOSITION
12/15/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2020
NPUB
NOTICE OF PUBLICATION
11/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/24/2020
DOCK
ASSIGNED TO EXAMINER
10/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/18/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2020
Continuous trademark protection
Get notified about every new filing that threatens PATIENT IN THE LAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.